Home
Hetero

Hetero Market Share Analysis for March 2026

Health > Biotechnology and Pharmaceuticals

Domainheteroworld.com

Year Founded1994

Employees> 10001

Annual Revenue> $1B

Hetero

Hetero (including company regionals)

heteroworld.com

See more website traffic and engagement information

Hetero Revenue up to March 2026 is > 1B

revenue generated by Hetero top domains

Hetero top domains revenue over 3 years

Revenue for Hetero top domains

heteroworld.com> 1B

See more with Sales Intelligence

Total visits to Hetero's top domains

Understand Hetero market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Hetero's top domains

Analyze Hetero engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Hetero's top domains

See how Hetero keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Hetero top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Hetero

These are the website technologies, by industry, used by Hetero top domains

Advertising (3)

DoubleClick

Mobile (3)

Meta Viewport

Widget (3)

reCAPTCHA

Audio Video Media (2)

YouTube

More Technologies

5

See all

News & Signals from Hetero

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHetero Labs partners with MedicinesPatentPool.Hetero entered into a non-exclusive voluntary licensing agreement with Medicines Patent Pool (MPP) for manufacturing and sale of a generic version of Pfizer's COVID-19 oral antiviral treatment candidate nirmatrelvir, which is co-packaged with ritonavir (nirmatrelvir; ritonavir), in LMICs.

NewsHetero Labs invests into assets: manufacturing facility in the amount of $22.6M in Vemagal, India, Southern Asia, Asia.It also sold its manufacturing facility at Vemagal in Karnataka to Hetero Labs for Rs 180 crore.

NewsHetero Labs is developing generic version of molnupiravir in India.Hetero is developing their own generic version of molnupiravir in India under a voluntary license agreement with Merck.